Abbott Laboratories has disclosed that it is investigating a cybersecurity incident involving unauthorized access to a limited number of internal systems within its Cancer Diagnostics business. The healthcare giant confirmed the breach this week, emphasizing that the incident remains contained to a specific business unit and has not disrupted broader company operations; the unauthorized access […]
The post Abbott Confirms Unauthorized Access to Cancer Diagnostics Systems appeared first on Cyber Security News.